First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma

Lazaros Lazaridis, Elisabeth Bumes, Dorothee Caecilia Spille, Tim Schulz, Sina Heider, Sarina Agkatsev, Teresa Schmidt, Tobias Blau, Christoph Oster, Jonas Feldheim, Walter Stummer, Almuth Friederike Kessler, Clemens Seidel, Oliver Grauer, Peter Hau, Ulrich Sure, Kathy Keyvani, Ulrich Herrlinger, Christoph Kleinschnitz, Martin StuschkeKen Herrmann, Cornelius Deuschl, Stella Breuer, Elke Hattingen, Bjoern Scheffler, Sied Kebir, Martin Glas

Research output: Contribution to journalOriginal Articlepeer-review

15 Citations (Web of Science)
Original languageEnglish
JournalNEURO-ONCOLOGY ADVANCES
DOIs
Publication statusPublished - 2022

Cite this